Quick Answer
Stereotaxis, Inc. reported Cash and Equivalents of $13.42 million for fiscal year 2025.
Stereotaxis, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $13.42M | +9.9% |
| 2024 | $12.22M | -38.4% |
| 2023 | $19.82M | +130.8% |
| 2022 | $8.59M | -77.8% |
| 2021 | $38.74M | -11.8% |
| 2020 | $43.94M | +45.6% |
| 2019 | $30.18M | +179.6% |
| 2018 | $10.80M | +192.9% |
| 2017 | $3.69M | -56.6% |
| 2016 | $8.50M | +52.0% |
| 2015 | $5.59M | -23.1% |
| 2014 | $7.27M | -47.2% |
| 2013 | $13.78M | +77.1% |
| 2012 | $7.78M | -44.3% |
| 2011 | $13.95M | -60.4% |
| 2010 | $35.25M | +15.4% |
| 2009 | $30.55M | +0.6% |
| 2008 | $30.36M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.51M | -1.5% | +50.8% |
| June 30, 2025 | $6.97M | -52.6% | -34.3% |
| March 31, 2025 | $10.60M | -39.9% | -13.2% |
| December 31, 2024 | $12.22M | -38.4% | +14.6% |
| September 30, 2024 | $10.66M | -51.8% | -27.4% |
| June 30, 2024 | $14.68M | -35.8% | -16.7% |
| March 31, 2024 | $17.63M | +213.6% | -11.0% |
| December 31, 2023 | $19.82M | +130.8% | -10.3% |
- Stereotaxis, Inc. showed an increase of +9.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Stereotaxis, Inc.’s cash and equivalents has declined by 55.8% (from $30.36 million to $13.42 million).
- The most recent figure is from Stereotaxis, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: